secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2025-06-02T23:59:59+00:00
Accession:  0001842952-25-000051
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics updates corporate presentation for June 2025
-----------------------------------------------------------------

- Company issued an updated corporate presentation dated June 2025.
- Presentation emphasizes T cell engager platform for solid tumors.
- Slide 17 of the presentation is incorporated by reference under Item 8.01.
- No clinical data, financial results, or guidance were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295225000051/0001842952-25-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295225000051/cntx-20250602.htm
  HTML page:      https://secwatch.observer/filing/0001842952-25-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer